Fresenius Medical Care AG FMCQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.65B | 5.40B | 5.90B | 5.71B | 5.44B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.65B | 5.40B | 5.90B | 5.71B | 5.44B |
| Cost of Revenue | 4.13B | 4.02B | 4.29B | 4.26B | 4.06B |
| Gross Profit | 1.52B | 1.38B | 1.62B | 1.45B | 1.38B |
| SG&A Expenses | 856.04M | 876.27M | 913.38M | 824.74M | 898.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 12.46M | 19.53M | -31.32M | -3.14M | -11.50M |
| Total Operating Expenses | 5.04B | 4.96B | 5.21B | 5.12B | 4.99B |
| Operating Income | 609.02M | 439.40M | 689.18M | 586.57M | 447.62M |
| Income Before Tax | 445.46M | 242.80M | 591.90M | 470.65M | 397.85M |
| Income Tax Expenses | 104.48M | 50.02M | 123.91M | 87.95M | 88.82M |
| Earnings from Continuing Operations | 340.98M | 192.77M | 467.99M | 382.70M | 309.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -86.99M | -55.26M | -87.24M | -61.43M | -53.37M |
| Net Income | 253.99M | 137.51M | 380.75M | 321.27M | 255.67M |
| EBIT | 609.02M | 439.40M | 689.18M | 586.57M | 447.62M |
| EBITDA | 1.02B | 851.52M | 908.19M | 997.91M | 851.18M |
| EPS Basic | 0.95 | 0.50 | 1.33 | 1.10 | 0.87 |
| Normalized Basic EPS | 0.76 | 0.69 | 1.07 | 0.95 | 0.66 |
| EPS Diluted | 0.94 | 0.50 | 1.33 | 1.10 | 0.87 |
| Normalized Diluted EPS | 0.76 | 0.69 | 1.07 | 0.95 | 0.66 |
| Average Basic Shares Outstanding | 268.44M | 275.25M | 285.91M | 292.10M | 293.41M |
| Average Diluted Shares Outstanding | 268.44M | 275.25M | 285.91M | 292.10M | 293.41M |
| Dividend Per Share | -- | -- | 1.73 | -- | -- |
| Payout Ratio | 183.24% | -- | 0.00% | 0.00% | 187.56% |